🇺🇸 FDA
Patent

US 8318906

EMP2 antibodies and their therapeutic uses

granted A61KA61K39/39558A61K45/06

Quick answer

US patent 8318906 (EMP2 antibodies and their therapeutic uses) held by The Regents of the University of California expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K39/39558, A61K45/06, A61P, A61P35/00